Etidocaine Hydrochloride
CAS No. 36637-19-1
Etidocaine Hydrochloride ( Duranest | W-19053 | W 19053 | W19053 )
产品货号. M27981 CAS No. 36637-19-1
盐酸依多卡因是一种长效麻醉剂和电压门控钠通道阻滞剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2373 | 有现货 |
|
| 10MG | ¥3548 | 有现货 |
|
| 25MG | ¥5638 | 有现货 |
|
| 50MG | ¥7962 | 有现货 |
|
| 100MG | ¥10692 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Etidocaine Hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述盐酸依多卡因是一种长效麻醉剂和电压门控钠通道阻滞剂。
-
产品描述Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
体外实验IGL-EDC formulations can induce a significant increase in human fibroblasts survival. Cell Viability Assay Cell Line:Human fibroblasts cells Concentration:0, 4, 8, 16, 24 mM Incubation Time:4, 6 and 24 h Result:Showed that cell survival decreased in a (EDC) concentration with time-dependent manner.
-
体内实验Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit. Animal Model:Adult Swiss Webster male mice Dosage:0.0075% Administration:Etidocaine(spinal injection, 0.0075%, once)Result:Did not show postinjection neurologic deficit.
-
同义词Duranest | W-19053 | W 19053 | W19053
-
通路Membrane Transporter/Ion Channel
-
靶点Sodium Channel
-
受体D2|5-HT2A
-
研究领域——
-
适应症——
化学信息
-
CAS Number36637-19-1
-
分子量313.89
-
分子式C17H30ClN2O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 62.5 mg/mL (199.76 mM)
-
SMILESCl.CCC[NH](CC)C(CC)C(=O)Nc1c(C)cccc1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yamazaki S, et al. Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans. Drug Metab Dispos. 2004 Apr;32(4):398-404.
产品手册
关联产品
-
Lidocaine hydrochlor...
盐酸利多卡因盐是一种酰胺局部麻醉剂,在体外和体内具有抗炎特性。
-
Ropivacaine
罗哌卡因是一种属于氨基酰胺类的局部麻醉药。
-
DPI 201-106
DPI 201-106 是一种心脏选择性抑制剂,可抑制 TTX 抗性 h1 Na 通道失活,从而产生正性肌力作用。
021-51111890
购物车()
sales@molnova.cn

